Insider · CIK 0001827307

Vance Holly

Reports to the SEC for 1 company · SEATTLE, WA

Transactions

Companies

Filings

CIK

0001827307

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-08-03	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	General Counsel	AAward	+100K sh	—	—	100,000
2020-10-19	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	General Counsel	AAward	+220K sh	—	—	220,000

C/O NEOLEUKIN THERAPEUTICS, INC. 360-1616 EASTLAKE AVENUE E.

SEATTLE, WA, 98102